Glycosphingolipid antibodies in serum in patients with sciatica

Spine

Volumn 27, Issue 4, 2002, Pages 380-386

  Brisby, Helena ^a   Balagué, Federico ^b   Schafer, Dominique ^b   Sheikhzadeh, Ali ^c   Lekman, Annika ^a   Nordin, Margareta ^c   Rydevik, Bjrn ^a   Fredman, Pam ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Hopital Cantonal de Fribourg   (Switzerland)

^c NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Antibody; Autoimmune; Disc herniation; Glycosphingolipid; Sciatica

Indexed keywords

ANTIBODY; AUTOANTIBODY; GLYCOSPHINGOLIPID; GLYCOSPHINGOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL EXAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INTERVERTEBRAL DISKECTOMY; ISCHIALGIA; LUMBAR DISK HERNIA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RADICULAR PAIN;

ACUTE DISEASE; ADULT; AGED; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLYCOSPHINGOLIPIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERVERTEBRAL DISK DISPLACEMENT; MALE; MIDDLE AGED; REFERENCE VALUES; SCIATICA;

EID: 0037082560     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200202150-00011     Document Type: Article

References (45)

1. Recovery of severe sciatica
2. Antiglycolipid antibodies in motor neuropathies
3. Auto-immune response to nucleus pulposus in the rabbit
4. Markers of nerve tissue injury markers in the cetebrospinal fluid in patients with lumbar disc herniation
5. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica
6. Antisulphatide antibodies in neuropathy: Clinical and electrophysiologic correlates
7. Vesicular disruption of myelin in autoimmune demyelination
8. The Oswestry Low Back Pain Disability Questionnaire
9. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin
10. Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glycoronyl-3-sulfate epitope
11. Glycosphingolipid as a potential diagnostic markers and/or antigens in neurological disorders
12. The role of antiglycolipid antibodies in neurological diseases
13. Antiglycosphingolipid immune responses in neurology: The Vienna experience with isotypes, subclasses, and disease
14. Autoimmunity in degenerative disc disease of the lumbar spine
15. Immunocytochemical localization of immunoglobulins in disc herniations
16. Failure of anti-GM1 IgG and IgM to induce conduction block following intraneural transfer
17. Temporal study of immunoglobulin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis
18. Inflammatory neuropathies
19. Exogenous TNF-α mimics nucleus pulposus-induced neuropathology: Molecular, histologic, and behavioral comparisons in rats
20. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyetinating potyneuropathy
21. Glycosphingolipid antibodies and blood nerve barrier in autoimmune demyelinative neuropathy
22. Cultured, autologous nucleus pulposus cells induce functional changes in spinal nerve roots
23. Possible mechanism of painful radiculopathy in lumbar disc herniation
24. Immunological investigation of chronic inflammatory demyelinating polyradiculopathy
25. Characterization of anti-ganglioside antibodies present in normal human plasma
26. Monosialogangliodide (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody
27. Autotogous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots
28. Inflammatogenic properties of nucleus pulposus
29. Ultrastructural changes in spinal nerve roots induced by autologous nucleus pulposus
30. Pathogenesis of sciatic pain; role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion
31. Tumor necrosis factor α and nucleus-pulposus-induced nerve root injury
32. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies
33. Presence and distribution of antigenantibody complexes in the herniated nucleus pulposus
34. Cerebrospinal fluid proteins as indicators of nerve toot compression in patients with sciatica caused by disc herniation
35. Elevated cerebrospinal fluid proteins in sciatica caused by disc herniation
36. Protein markers in CSF in experimental nerve root injury: A study of the effects of slow-onset chronic compression, or biochemical effects of nucleus pulposus, on sacral nerve roots
37. IgG, IgM concentration in the prolapsed human intervertebral disc and sciatica etiology
38. Human brain gangliosides: Developmental changes from early fetal stage to advanced age
39. Gangliosides and allied glycosphingolipids in human peripheral nerve and spinat cord
40. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelin fibers
41. Inflammatory cytokines in the herniated disc of the lumbar spine
42. Serum antibodies to gangliosides in Guillain-Barré syndrome
43. The Spitzer Quality of Life Index: Its performance as a measure
44. Sphingolipids as receptor modulators: An overview
45. Serum immunoglobulins in brain tumours and lumbar disc diseases